Literature DB >> 22927528

Breast cancer risk reduction: no pain, no gain?

Clifford A Hudis, Kotha Subbaramaiah, Patrick G Morris, Andrew J Dannenberg.   

Abstract

Entities:  

Mesh：

Substances：

Year:  2012        PMID： 22927528     DOI： 10.1200/JCO.2012.44.8597

Source DB:  PubMed          Journal:  J Clin Oncol        ISSN： 0732-183X            Impact factor:   44.544


× No keyword cloud information.
  5 in total

1.  Aspirin and serum estrogens in postmenopausal women: a randomized controlled clinical trial.

Authors:  Catherine Duggan; Ching-Yun Wang; Liren Xiao; Anne McTiernan
Journal:  Cancer Prev Res (Phila)       Date:  2014-06-12

2.  Molecular pathways: adipose inflammation as a mediator of obesity-associated cancer.

Authors:  Louise R Howe; Kotha Subbaramaiah; Clifford A Hudis; Andrew J Dannenberg
Journal:  Clin Cancer Res       Date:  2013-08-19       Impact factor: 12.531

3.  Aspirin-triggered proresolving mediators stimulate resolution in cancer.

Authors:  Molly M Gilligan; Allison Gartung; Megan L Sulciner; Paul C Norris; Vikas P Sukhatme; Diane R Bielenberg; Sui Huang; Mark W Kieran; Charles N Serhan; Dipak Panigrahy
Journal:  Proc Natl Acad Sci U S A       Date:  2019-03-12       Impact factor: 11.205

Review 4.  Targeting obesity-related adipose tissue dysfunction to prevent cancer development and progression.

Authors:  Ayca Gucalp; Neil M Iyengar; Clifford A Hudis; Andrew J Dannenberg
Journal:  Semin Oncol       Date:  2015-09-08       Impact factor: 4.929

5.  The protein kinase promiscuities in the cancer-preventive mechanisms of NSAIDs.

Authors:  Povilas Norvaisas; Diana Chan; Kenji Yokoi; Bhuvanesh Dave; Arturas Ziemys
Journal:  Eur J Cancer Prev       Date:  2016-01       Impact factor: 2.497
  5 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.